News

SiDMAP’s new Japanese clients will use SiDMAP’s services to study the mechanisms of action and identify potential efficacy biomarkers for drugs designed to treat diseases such as diabetes,

Tekmira Pharmaceuticals, a biopharmaceutical company, has announced that one of the company’s collaborators, Alnylam Pharmaceuticals, has initiated a Phase I human clinical trial of ALN-VSP in the US.

CardioNet, a wireless medical technology company, and Biotel, a developer of medical devices and related software products, have entered into a binding definitive merger agreement, pursuant to which,

Biovista, a drug development services company, has reported that BVA-101, its drug targeting multiple sclerosis, has shown significant positive results in the myelin oligodendrocyte protein-induced experimental allergic encephalomyelitis

Osiris Therapeutics, a stem cell therapeutic company, has started treatment of the first patient in a Phase II clinical trial evaluating Prochymal for the treatment of heart attacks.

Tongjitang Chinese Medicines Company, a developer and marketer of modernized traditional Chinese medicine, has acquired 100% of Anhui Jingfang Pharmaceutical for RMB60 million in cash. Tongjitang has paid

Amylin Pharmaceuticals, a biopharmaceutical company, Eli Lilly and Company and Alkermes, a biotechnology company, have reported positive results from Duration-2, the second in a series of studies designed

GlaxoSmithKline has received the European Commission authorization for Synflorix, a pediatric pneumococcal vaccine to protect against life-threatening diseases such as meningitis and bacteraemic pneumonia, as well as middle

According to Emisphere, the Eligen technology is a unique and improved delivery method for therapeutic molecules and nutritional supplements. The key benefit of Eligen technology is that it